Knowledge Center

Article / Sep 23, 2014

Quality Metrics - A Case for an FDA Dean's List

Authors:
  • Guy Villax
Source:
Pharmaceutical Technology, September 2014

The author (Guy Villax)听presents arguments for an FDA Dean's List as a means to drive the right behaviors in the industry.

FDA is moving in the right direction when it looks to rank quality across pharmaceutical manufacturing sites. However quality is a matter of culture rather than metrics or compliance.

  • Read the extended听version with links to references, examples and case studies听
  • Read the article in Pharmaceutical Technology听听

听

Also in the Knowledge Center

Related Content

Hydrogenations

四色AV has vast experience in developing hydrogenation processes using both heterogeneous and homogeneous catalysis.

Page
Read more

What we do

四色AV is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more

Drug Substance Technologies

We constantly innovate to find better, more efficient ways of doing things.

Page
Read more